GENE ONLINE|News &
Opinion
Blog

Drug Approval
FDA Suspends Valneva’s Ixchiq Chikungunya Vaccine Over Safety Risks
2025-08-28
GSK Secures Approval From Chinese NMPA for Nucala, its Add-On-Therapy to Treat CRSwNP
2025-01-07
Eli Lilly’s Tirzepatide Gets Approval in China for Weight Loss Management
2024-07-22
Alzheimer’s Drug LEQEMBI Approved for Treatment in Hong Kong
2024-07-12
Sanofi and Regeneron’s Dupixent Approved as First-in-World Treatment For Uncontrolled COPD
2024-07-04
Santhera, ReveraGen’s Duchenne Drug Accepted By EMA While Anticipating FDA Priority Review
2022-11-01
AstraZeneca Welcomes Neurofibromatosis And Asthma Treatment Approvals in Japan
2022-09-28
Daiichi Sankyo Wins Approval For Cancer Treatment in Japan
2022-09-26
Mounting Criticisms of FDA’s Accelerated Approval Pathway Could Prompt Changes to the System
2022-08-25
Three Previously Approved Treatments Show Anti-monkeypox Activity
2022-08-08
Everest Medicines Secures Breast Cancer Drug Approval in China
2022-06-13
WSJ Health Forum 2022: Psychedelics Set to Take Center Stage in Mental Wellness
2022-03-24
FDA Approves Drug for Schizophrenia in Pediatric Patients
2022-01-10
GeneOnline’s Pick: Notable Novel FDA Approved Drugs in 2021
2022-01-05
FDA Greenlights Blueprint Medicines’ Ayvakit for Rare Disease Treatment
2021-06-21
1 2
LATEST
Health Insurers Adopt Wearable Data Tracking Models Similar to Automotive Telematics
2026-08-14
Biogen’s Alzheimer’s Tau Drug Splits Experts: Can Diranersen Challenge Leqembi?
2026-08-14
Definium’s Psychedelic Anxiety Drug DT120 Moves Closer to the Mainstream With a Phase 3 Win
2026-08-14
JAMA Network Open Study Links Agent Orange and Burn Pit Exposure to Veteran Health Outcomes
2026-08-14
La Mojana Earthworks Reveal Long-Term Sustainable Water Management by Pre-Hispanic Societies
2026-08-13
Grant Evaluators Divided Over Prioritizing Past Performance Versus Future Potential
2026-08-13
UC Riverside Study Finds High-Intensity Running Does Not Reduce Lifespan in Mice
2026-08-13
Scroll to Top